The stock of Oragenics Inc (OGEN) has gone down by -14.96% for the week, with a -22.86% drop in the past month and a -81.54% drop in the past quarter. The volatility ratio for the week is 14.15%, and the volatility levels for the past 30 days are 9.44% for OGEN. The simple moving average for the past 20 days is -19.61% for OGEN’s stock, with a -68.21% simple moving average for the past 200 days.
Is It Worth Investing in Oragenics Inc (AMEX: OGEN) Right Now?
The 36-month beta value for OGEN is at 0.36. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OGEN is 3.82M, and currently, shorts hold a 1.08% of that float. The average trading volume for OGEN on April 17, 2024 was 94.92K shares.
OGEN) stock’s latest price update
The stock price of Oragenics Inc (AMEX: OGEN) has dropped by -11.48 compared to previous close of 1.22. Despite this, the company has seen a fall of -14.96% in its stock price over the last five trading days. InvestorPlace reported 2024-02-28 that Oragenics (NYSEMKT: OGEN ) stock is falling on Wednesday after the antibiotics development company announced details of a public offering for its shares. Oragenics is selling 1.4 million shares of OGEN stock for $1.50 each.
OGEN Trading at -46.30% from the 50-Day Moving Average
After a stumble in the market that brought OGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.05% of loss for the given period.
Volatility was left at 9.44%, however, over the last 30 days, the volatility rate increased by 14.15%, as shares sank -23.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -54.81% lower at present.
During the last 5 trading sessions, OGEN fell by -14.96%, which changed the moving average for the period of 200-days by -67.95% in comparison to the 20-day moving average, which settled at $1.3270. In addition, Oragenics Inc saw -80.80% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OGEN starting from Telling Fred, who sale 3,500 shares at the price of $3.57 back on Nov 30 ’23. After this action, Telling Fred now owns 38,345 shares of Oragenics Inc, valued at $12,488 using the latest closing price.
Stock Fundamentals for OGEN
Current profitability levels for the company are sitting at:
- -282.35 for the present operating margin
- 0.27 for the gross margin
The net margin for Oragenics Inc stands at -547.08. The total capital return value is set at -3.36. Equity return is now at value -255.36, with -209.44 for asset returns.
Based on Oragenics Inc (OGEN), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -22.61. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -347.53.
Currently, EBITDA for the company is -10.64 million with net debt to EBITDA at 0.3. When we switch over and look at the enterprise to sales, we see a ratio of 44.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.15.
Conclusion
In conclusion, Oragenics Inc (OGEN) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
